Maternal Plasma Nerve Growth Factor at the 11+0-13+6 Weeks' Scan as a Potential Angiogenic Marker of Preeclampsia: A Pilot Study

Publisher： Karger

E-ISSN： 1421-9964|41|3|202-208

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.41, Iss.3, 2016-08, pp. : 202-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 3, 2013-02 ,pp. : 164-172

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor Isoforms 1 and 2 at 11-13, 20-24 and 30-34 Weeks' Gestation in Late-Onset Pre-Eclampsia and Small for Gestational Age Neonates

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-03 ,pp. : 249-257

Karger

Access to resources Recommend Favorite

Maternal Serum Adiponectin at 11–13 Weeks of Gestation in Preeclampsia

By  

Fetal Diagnosis and Therapy, Vol. 29, Iss. 3, 2011-01 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 2, 2014-01 ,pp. : 106-116

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ Gestation

By  

Fetal Diagnosis and Therapy, Vol. 31, Iss. 2, 2012-01 ,pp. : 87-93

Karger

Access to resources Recommend Favorite